课题基金 / 基金详情

Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism

Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism
利用葡萄糖转运和适应性禁食反应来调节肝脏代谢
批准号:
10672277
负责人:
Brian Jesse DeBosch
金额:
$40.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-25 至 2025-07-31

项目摘要

项目成果

Brian Jesse DeBosch的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Non-alcoholic fatty liver disease (NAFLD) is a common and morbid metabolic disease that independently predicts development of type 2 diabetes mellitus and its cardiovascular, renal and retinal complications. More than one billion individuals have NAFLD, making this the most common chronic liver disease worldwide. A barrier to effectively treating and preventing this disease and its complications is the lack of effective NAFLD treatments. Our long-term goal is to understand the underlying glucose metabolic pathways that lead to NAFLD, so that we can precisely modulate these pathways to treat or prevent its progression. We identified the hepatic carbohydrate carrier, GLUT8, as a therapeutic target because: (i.) GLUT8 promotes diet-induced hepatic steatosis and metabolic syndrome and (ii.) the disaccharide and glucose mimetic trehalose inhibits GLUT8 and activates an adaptive fasting response (e.g. AMP kinase and autophagy), to reverse hepatic steatosis. The objective here is to define the interaction between hepatocyte glucose transport, trehalose, and adaptive hepatocyte fasting responses. Our preliminary data suggest that acute hepatocyte-selective GLUT8 knockdown and hepatocyte- specific germline GLUT8 gene deletion (GLUT8 LKO mice) each induce hepatocyte fasting signals and peripheral thermogenesis. We therefore hypothesize that genetic and pharmacological hepatocyte GLUT8 blockade induces thermogenesis and confers resistance to hepatic steatosis. The two Specific Aims are to 1) Identify mechanisms by which GLUT8 regulates hepatic and extrahepatic metabolism, and 2) Define mechanisms mediating trehalose-induced thermogenesis and protection from NAFLD. We will accomplish these aims by leveraging novel experimental mouse models and unique in vivo imaging techniques. Completing these aims informs how to optimally target hepatocyte glucose transport to augment hepatocyte and whole-organism energy homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging arginase biology against metabolic disease
  • 批准号:
    10583279
  • 项目类别:
  • 资助金额:
    $43.69万
  • 财政年份:
    2023
  • 负责人:
    Brian Jesse DeBosch
  • 依托单位:
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism
  • 批准号:
    10475158
  • 项目类别:
  • 资助金额:
    $44.02万
  • 财政年份:
    2021
  • 负责人:
    Brian Jesse DeBosch
  • 依托单位:
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolism
  • 批准号:
    10295349
  • 项目类别:
  • 资助金额:
    $44.82万
  • 财政年份:
    2021
  • 负责人:
    Brian Jesse DeBosch
  • 依托单位:
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response
  • 批准号:
    10442453
  • 项目类别:
  • 资助金额:
    $62.96万
  • 财政年份:
    2020
  • 负责人:
    Brian Jesse DeBosch
  • 依托单位:
海外基金